
pmid: 19845167
With more widespread use of imaging, cystic neoplasms of the pancreas are being diagnosed with increased frequency. Serous cystadenomas are the most common type of cystic neoplasm of the pancreas and have a natural history and malignant potential different than that of other cystic neoplasms. Although characteristic findings on imaging may be supportive, definitive diagnosis of these lesions often cannot be made by imaging alone. Endoscopic ultrasound with fine needle aspiration and cyst aspiration may facilitate the diagnosis, and after definitive diagnosis, patients with lesions that are small and asymptomatic may be followed with serial imaging. If definitive diagnosis cannot be made or if the patient is symptomatic, resection is warranted. In addition, large (> 4 cm) serous cystadenomas should be resected in appropriate surgical candidates given their propensity for growth and developing symptoms.
Cholangiopancreatography, Endoscopic Retrograde, Pancreatic Neoplasms, Pancreatectomy, Cystadenoma, Serous, Prevalence, Humans, Prognosis, Tomography, X-Ray Computed, Magnetic Resonance Imaging
Cholangiopancreatography, Endoscopic Retrograde, Pancreatic Neoplasms, Pancreatectomy, Cystadenoma, Serous, Prevalence, Humans, Prognosis, Tomography, X-Ray Computed, Magnetic Resonance Imaging
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 50 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
